Nov. 25, 2022 Price forecast | 2 weeks: -1.59% | 1 month: -4.12% | 3 months: -5.59%


TMCI stock forecast

Our latest prediction for Treace Medical Concepts Inc's stock price was made on the Nov. 25, 2022 when the stock price was at 22.21$.

In the short term (2weeks), TMCI's stock price should underperform the market by -1.59%. During that period the price should oscillate between -9.22% and +2.02%.

In the medium term (3months), TMCI's stock price should underperform the market by -5.59%. During that period the price should oscillate between -34.89% and +18.27%.

Create a solid portfolio with TMCI

Add TMCI to your portfolio and optimize it!


About Treace Medical Concepts Inc

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion Correction™ system is designed to reproducibly correct all three planes of the bunion deformity and address the root cause of the bunion, while allowing patients to get back to their active lives quickly.

At the moment the company generates 125M USD in revenues.

On its last earning announcement, the company reported a loss of None$ per share.

The book value per share is -0.14$

Treace Medical Concepts Inc website


Three months stock forecastNov. 25, 2022


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
125M 80.80% -36M -29.43% -25M - - - 55M -0.14 - - -